Method for treating psoriasis

US9334325B2 · kind B2 · utility

Assignee

• Biotest AG · DE

Inventors

• Frank Osterroth · Dietzenbach, DE
• Silke Aigner · Bischofswerda, DE
• Matthias Germer · Langen, DE
• Christoph Uherek · Seligenstadt, DE
• Elmar Kraus · Bad Vilbel, DE
• Andrea Wartenberg-Demand · Linden, DE
• Daniele Wolf · Dreieich, DE
• Sibylle Kaiser · Zwingenberg, DE
• Juergen Lindner · Frankfurt, DE
• Christoph Bruecher · Eschborn, DE
• Benjamin Daelken · Frankfurt am Main, DE

Key dates

• Filing date: Sep 13, 2010
• Grant date: May 10, 2016
• Expiry date: Sep 13, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides a pharmaceutical composition for treating an autoimmune disease comprising a pharmaceutically acceptable carrier and an agent capable of activating CD4+CD25+ regulatory T cells, wherein the composition is to be administered to a subject in a dose of the agent from 0.2 mg to 30 mg.